| Revenue growth | 6% YoY for FY26. |
|---|---|
| Margins | Compressed to 6.2% from 13.3% due to raw material and competition. |
| Demand visibility | Mixed; improving for Vanillin, impacted by conflicts elsewhere. |
| Management confidence | High for Blends segment growth. |
Growth
FY26 Revenue grew 6% to ₹17,233 mn; however, Adjusted EBITDA fell 50% YoY to ₹1,069 mn.
Outlook
Expects Vanillin recovery post-US tariff withdrawal; Blends targeting high momentum (April revenue ₹1,050+ mn); CFS Europe liquidation ongoing.
Risks
Geopolitical conflicts impacting raw material costs, logistics, and working capital; Chinese predatory pricing and oversupply in Straights.
Earnings Call filed with NSE, NSE: CAMLINFINE. Summary written with AI assistance from the document.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹95.00
- Market cap
- ₹1,825 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- 310.2×Sector 37.2×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences filed a Postal Ballot Notice seeking approval to appoint Mr. Atul Pradhan as Non-Executive Independent Director. E-voting runs September 17 to October 16, 2026.
Camlin Fine Sciences Management Change
Camlin Fine Sciences appointed Mr. Atul Pradhan as Additional Non-Executive Independent Director effective September 11, 2026. The appointment is subject to shareholder approval via postal ballot.
Camlin Fine Sciences Earnings Call Transcript: Key Takeaways
Camlin Fine Sciences reported Q1 FY27 revenue of INR 5,199 million, up 28% YoY, though EBITDA margins were pressured to 4% by high raw material and freight costs.
- Call
- Guides 25% growth
Camlin Fine Sciences Investor Presentation: Key Takeaways
Camlin Fine Sciences reported record quarterly revenue of Rs 5,199 Mn for Q1FY27, up 27.5% YoY, driven by strong growth in Specialty Ingredients and Aroma segments.
Camlin Fine Sciences Q1 FY27 Results: Net Loss of ₹33.6 Cr, Loss Widens
Camlin Fine Sciences Ltd reported revenue from operations of ₹519.9 Cr (+27.5% YoY) and a net loss of ₹33.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹33.6 Cr
Camlin Fine Sciences Annual General Meeting
Camlin Fine Sciences Limited held its 33rd Annual General Meeting on August 11, 2026. All resolutions proposed in the notice were passed by the shareholders.